Our scientists support your drug discovery and development journey through all research phases with our comprehensive expertise and state-of-the-art technologies. Trust Nuvisan to mitigate risks and accelerate your drug development process, helping ensure your success from target identification to clinical trials.
Partner with us to identify and validate drug targets efficiently. We employ advanced techniques such as CRISPR/Cas9, RNA interference and single-cell sequencing to tailor models and evaluate target expression. We conduct detailed assessments of assay feasibility and druggability to mitigate risks in your project.
LEARN MOREOur integrated pipeline accelerates the discovery of lead compounds through high-throughput, fragment and virtual screening. Our medicinal chemists leverage extensive pharmaceutical experience to help transform hits into viable leads, supported by sophisticated biophysical and structural biology analyses.
LEARN MOREWe optimise lead molecules for preclinical development through interdisciplinary collaboration. Our expertise includes ADME optimisation, mode-of-action characterisation and efficacy assessment using in vivo models, helping ensure your candidate is robust and well-characterised.
Bridging discovery and clinical stages, we manage chemical scale-up, formulation development, bioanalysis, DMPK and toxicology testing. Our thorough preparation helps ensure your drug candidate is safe and effective before human trials, supported by reliable analytical methods and clinical trial supply expertise.
Expedite your drug’s journey to market with our comprehensive clinical solutions. From protocol development to regulatory support, we manage all phases of clinical trials. Our experienced team ensures seamless study implementation, data management and statistical analysis, guiding you through the complexities of clinical development.
Contact Us
Search